SCHEMBL30833102

SCHEMBL30833102

CC(C)(C)OC(=O)N1CCN(c2cc(Cl)cnc2C2=CCOCC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 2/20 0.42
SKP1 P63208 2/20 0.42
SKP2 Q13309 2/20 0.42
TBK1 Q9UHD2 1/20 0.40
MAPT P10636 3/20 0.39
SMARCA2 P51531 1/20 0.39
SMARCA4 P51532 1/20 0.39
PBRM1 Q86U86 1/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
USP2 O75604 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TSHR P16473 1/20 0.38
GPR119 Q8TDV5 3/20 0.37
ALK Q9UM73 2/20 0.37
PGK1 P00558 1/20 0.37
CCNK O75909 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833145 0.88 CKS1B (0.42) CKS1BSKP1SKP2TBK1SMARCA2
SCHEMBL30833122 0.75 MAPT (0.47) MAPTSMN1; SMN2USP2MEN1KMT2A
SCHEMBL2366192 0.72 MEN1 (0.55) CKS1BSKP1SKP2MAPTPOLB
SCHEMBL31727494 0.71 NR1H2 (0.43) CKS1BSKP1SKP2MAPTSMARCA2
SCHEMBL21159159 0.71 GPR119 (0.60) CKS1BSKP1SKP2MAPTPOLB
SCHEMBL30899649 0.71 GRM1 (0.49) CDK9
SCHEMBL30366133 0.71 GRM1 (0.49) CDK9
SCHEMBL1833105 0.71 MTOR (0.41) TBK1MAPTSMN1; SMN2USP2
SCHEMBL21871400 0.70 PDK4 (0.52) SMN1; SMN2USP2GPR119
SCHEMBL31583898 0.70 GRM1 (0.55) CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587432-A1 M4 ACTIVATORS/MODULATORS AND USES THEREOF Cerevel Therapeutics, LLC (US) 2025-07-23 EP disclosed
WO-2024059249-A1 M4 ACTIVATORS/MODULATORS AND USES THEREOF CEREVEL THERAPEUTICS, LLC (US) 2024-03-21 WO disclosed